NKP30-B7-H6 interaction aggravates hepatocyte damage through up-regulation of interleukin-32 expression in hepatitis B virus-related acute-on-chronic liver failure

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Zou, Yong ^a   Bao, Junjie ^b   Pan, Xingfei ^c   Lu, Ying ^a   Liao, Sihong ^a   Wang, Xicheng ^d   Wang, Guoying ^a   Lin, Dongjun ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU WOMEN AND CHILDREN S MEDICAL CENTER   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

^d Zhangqiu People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B7 H6 PROTEIN; INTERLEUKIN 32; LYMPHOCYTE ANTIBODY; LYMPHOCYTE ANTIGEN; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3 ANTIBODY; UNCLASSIFIED DRUG; B7 ANTIGEN; B7-H6 ANTIGEN, HUMAN; IL32 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; NCR3 PROTEIN, HUMAN;

ACUTE ON CHRONIC LIVER FAILURE; ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE SEVERITY; FEMALE; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL DAMAGE; MALE; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE; UPREGULATION; COMPLICATION; DRUG EFFECTS; HEPATITIS B; LIVER; LIVER CELL; METABOLISM; MIDDLE AGED; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY; YOUNG ADULT;

ACUTE-ON-CHRONIC LIVER FAILURE; ADULT; APOPTOSIS; B7 ANTIGENS; CELL LINE, TUMOR; FEMALE; HEPATITIS B; HEPATOCYTES; HUMANS; INTERLEUKINS; KILLER CELLS, NATURAL; LIVER; MALE; MIDDLE AGED; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; UP-REGULATION; YOUNG ADULT;

EID: 84941948977     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0134568     Document Type: Article

References (25)

1. Marsden PA, Ning Q, Fung LS, Luo X, Chen Y, Mendicino M, et al. The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest. 2003;112:58-66. PMID: 12840059
2. Liu M, Chan CW, McGilvray I, Ning Q, Levy GA. Fulminant viral hepatitis: molecular and cellular basis, and clinical implications. Expert Rex Mol Med. 2001;3:1-19.
3. Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int. 2009;3:269-282. doi: 10.1007/s12072-008-9106-x PMID: 19669378
4. Liu Q, Liu Z, Wang T, Wang Q, Shi X, Dao W. Characteristics of acute and sub-acute liver failure in China: nomination, classification and interval. J Gastroenterol Hepatol. 2007;22:2101-2106. PMID: 18031366
5. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004;38:S158-S168. PMID: 15602165
6. Liang TJ. Hepatitis B: the virus and disease. Hepatology. 2009;49:S13-S21 doi: 10.1002/hep. 22881 PMID: 19399811.
7. Wu Z, Han M, Chen T, Yan W, Ning Q. Acute liver failure: mechanisms of immune-mediated liver injury. Liver Int. 2010;30:782-794. doi: 10.1111/j.1478-3231.2010.02262.x PMID: 20492514
8. Roth E, Pircher H. IFN-gamma promotes Fas ligand- and perforin-mediated liver cell destruction by cytotoxic CD8 T cells. J Immunol. 2004;172:1588-1594. PMID: 14734739
9. Maini MK, Boni C, Lee CK, Larrubia JR, Reignat S, Ogg GS, et al. The role of virus-specific CD8 (+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med. 2000;191:1269-1280. PMID: 10770795
10. Zou Y, Chen T, Han M, Wang H, Yan W, Song G, et al. Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure. J Immunol. 2010;18:466-475.
11. Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, et al. Acute-on-chronic Liver failure: consensus recommendations of the Asian Pacific Association for The study of the liver (APASL). Hepatol Int. 2009;3:269-282. doi: 10.1007/s12072-008-9106-x PMID: 19669378
12. Xu Q, Pan X, Shu X, Cao H, Li X, Zhang K, et al. Increased interleukin-32 expression in chronic hepatitis B virus-infected liver. J Infect. 2012;65:336-342. doi: 10.1016/j.jinf.2012.05.009 PMID: 22687868
13. Brandt CS, Baratin M, Yi EC, Kennedy J, Gao Z, Fox B. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med. 2009;206:1495-1503. doi: 10.1084/jem.20090681 PMID: 19528259
14. Li Y, Wang Q, Mariuzza RA. Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6. J Exp Med. 2011, 208:703-714. doi: 10.1084/jem.20102548 PMID: 21422170
15. Dahl CA, Schall RP, He HL, Cairns JS. Identification of a novel gene expressed in activated natural killer cells and T cells. J Immunol. 1992;148:597-603. PMID: 1729377
16. Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA. Interleukin-32: a cytokine and inducer of TNFá. Immunity. 2005;22:131-142. PMID: 15664165
17. Shoda H, Fujio K, Yamaguchi Y, Okamoto A, Sawada T, Kochi Y, et al. Interactions between IL-32 and tumor necrosis factor á contribute to the exacerbation of immune-inflammatory diseases. Arthritis Res Ther. 2006;8:R166. PMID: 17078892
18. Nold MF, Nold-Petry CA, Pott GB, Zepp JA, Saavedra MT, Kim SH, et al. Endogenous IL-32 controls cytokine and HIV-1production. J Immunol. 2008;181:557-565. PMID: 18566422
19. Dinarello CA, Kim SH. IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis. 2006;65: iii61-iii64. PMID: 17038476
20. Cheon S, Lee JH, Park S, Bang SI, Lee WJ, Yoon DY, et al. Overexpression of IL-32 alpha increases natural killer cell-mediated killing through up-regulation of Fas and UL16-binding protein 2 (ULBP2) expression in human chronic myeloid leukemia cells. J Biol Chen. 2011;286:12049-12055.
21. Park MH, Song MJ, Cho MC, Moon DC, Yoon, Han SB, et al. Interleukin-32 enhances cytotoxic effect of natural killer cells to cancer cells via activation of death receptor 3. Immunology. 2012;135:63-72. doi: 10.1111/j.1365-2567.2011.03513.x PMID: 22043900
22. Pan X, Cao H, Lu J, Shu X, Xiong X, Hong X, et al. Interleukin-32 expression induced by hepatitis B virus protein X is mediated through activation of NF-êB. Mol Immunol. 2011;48:1573-1577. doi: 10. 1016/j.molimm.2011.03.012 PMID: 21481941
23. Zhang Z, Zou ZS, Fu JL, Cai L, Jin L, Liu YJ, et al. Severe dendritic cell perturbation is actively involved in the pathogenesis of acute-on-chronic hepatitis B liver failure. J Hepatol. 2008;49:396-406. doi: 10. 1016/j.jhep. 2008.05.017 PMID: 18644645
24. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med. 2002;195:343-351. PMID: 11828009
25. Jung MY, Son MH, Kim SH, Cho D, Kim TS. IL-32gamma induces the maturation of dendritic cells with Th1- and Th17-polarizing ability through enhanced IL-12 and IL-6 production. J Immunol. 2011;186:684-659.